Cargando…
Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
We report a rare case of acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) after coronavirus disease 2019 (COVID‐19) vaccination. Clinicians should be aware of this COVID‐19 vaccination‐induced AE in IPF
Autores principales: | Sugino, Keishi, Ono, Hirotaka, Saito, Mikako, Ando, Masahiro, Tsuboi, Eiyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556549/ https://www.ncbi.nlm.nih.gov/pubmed/36254333 http://dx.doi.org/10.1002/rcr2.1051 |
Ejemplares similares
-
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2021) -
Pleuroparenchymal fibroelastosis in mycobacterium avium complex lung disease
por: Sugino, Keishi, et al.
Publicado: (2023) -
Miliary opacities in pulmonary sarcoidosis
por: Sugino, Keishi, et al.
Publicado: (2020) -
Successful baricitinib treatment of refractory anti‐synthetase syndrome associated with interstitial lung disease
por: Sugino, Keishi, et al.
Publicado: (2023) -
Autoimmune pulmonary alveolar proteinosis presenting peripheral ground‐glass opacities
por: Sugino, Keishi, et al.
Publicado: (2018)